Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Alloxan Diabetes

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Alloxan Diabetes in 2 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Fu, M1
Yu, J1
Chen, Z1
Tang, Y1
Dong, R1
Yang, Y1
Luo, J1
Hu, S1
Tu, L1
Xu, X1
Alaeddine, LM1
Harb, F1
Hamza, M1
Dia, B1
Mogharbil, N1
Azar, NS1
Noureldein, MH1
El Khoury, M1
Sabra, R1
Eid, AA1

Other Studies

2 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Alloxan Diabetes

ArticleYear
Epoxyeicosatrienoic acids improve glucose homeostasis by preventing NF-κB-mediated transcription of SGLT2 in renal tubular epithelial cells.
    Molecular and cellular endocrinology, 2021, 03-01, Volume: 523

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Cell Line; Diabetes Mellitus, Experimental; Epithelial Cells;

2021
Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats.
    Translational research : the journal of laboratory and clinical medicine, 2021, Volume: 235

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomyopathies; Cytochrome P-450 Enzyme Sy

2021